IN165073B - - Google Patents

Info

Publication number
IN165073B
IN165073B IN344/MAS/87A IN344MA1987A IN165073B IN 165073 B IN165073 B IN 165073B IN 344MA1987 A IN344MA1987 A IN 344MA1987A IN 165073 B IN165073 B IN 165073B
Authority
IN
India
Application number
IN344/MAS/87A
Other languages
English (en)
Inventor
Ziya Ozel Huseyin
Original Assignee
Ziya Ozel Huseyin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ziya Ozel Huseyin filed Critical Ziya Ozel Huseyin
Publication of IN165073B publication Critical patent/IN165073B/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/24Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/415Assays involving biological materials from specific organisms or of a specific nature from plants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN344/MAS/87A 1986-05-13 1987-05-12 IN165073B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86272086A 1986-05-13 1986-05-13
US4843587A 1987-05-11 1987-05-11

Publications (1)

Publication Number Publication Date
IN165073B true IN165073B (de) 1989-08-12

Family

ID=26726121

Family Applications (1)

Application Number Title Priority Date Filing Date
IN344/MAS/87A IN165073B (de) 1986-05-13 1987-05-12

Country Status (14)

Country Link
US (1) US5135745A (de)
JP (1) JPS6322025A (de)
KR (1) KR880013565A (de)
CN (1) CN87104312A (de)
AU (1) AU626516B2 (de)
CA (1) CA1299100C (de)
DK (1) DK239687A (de)
FI (1) FI872106A (de)
IL (1) IL82516A0 (de)
IN (1) IN165073B (de)
MC (1) MC1811A1 (de)
NO (1) NO871978L (de)
NZ (1) NZ220295A (de)
PT (1) PT84857B (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6056999A (en) * 1998-09-24 2000-04-10 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
AU2003227319B2 (en) * 1998-09-24 2007-07-26 Ozelle Pharmaceuticals, Inc. Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof
KR100478146B1 (ko) * 2002-08-30 2005-03-22 재단법인 포항산업과학연구원 협죽도과 식물의 잎 추출물을 함유하는 고려잔디갈색퍼짐병 방제용 조성물 및 이를 이용하여 갈색퍼짐병을방제하는 방법
US20050112059A1 (en) * 2003-10-06 2005-05-26 Phoenix Biotechnology, Inc. Enhancement of radiotherapy by an exogenous cardiac glycoside
WO2005060951A2 (en) * 2003-12-19 2005-07-07 Bionaut Pharmaceuticals, Inc. Anti-neoplastic agents, combination therapies and related methods
JP2005289963A (ja) * 2004-03-12 2005-10-20 Hokubu Norin Koto Gakko Koenkai 抗腫瘍剤
US20070105790A1 (en) * 2004-09-02 2007-05-10 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using Na+/K+ ATPase inhibitors
WO2006028969A1 (en) * 2004-09-02 2006-03-16 Bionaut Pharmaceuticals, Inc. Pancreatic cancer treatment using na+/k+ atpase inhibitors
US20060135468A1 (en) * 2004-09-02 2006-06-22 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using NA+/K+ ATPase inhibitors
US20080027010A1 (en) * 2004-09-02 2008-01-31 Bionaut Pharmaceuticals, Inc. Treatment of refractory cancers using Na+/K+-ATPase inhibitors
WO2006029018A2 (en) * 2004-09-02 2006-03-16 Bionaut Pharmaceuticals, Inc. Combinatorial chemotherapy treatment using na+/k+-atpase inhibitors
EP1812010A2 (de) * 2004-10-18 2007-08-01 BTG International Limited Verwendung von na+/k+ atpase-hemmern und ihren antagonisten
US20060188536A1 (en) * 2005-02-15 2006-08-24 Phoenix Biotechnology Inc. Particles from processing of oleander leaves
JP2007008879A (ja) * 2005-06-30 2007-01-18 Yanbaru Green Health:Kk 抗腫瘍剤及びこれを含有する食品
US7402325B2 (en) * 2005-07-28 2008-07-22 Phoenix Biotechnology, Inc. Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander
EP1803461A1 (de) * 2005-12-27 2007-07-04 Heinz-Herbert Fiebig Therapeutische Verwendung eines Nerium-oleander Blätterextrakts
WO2008078362A1 (ja) * 2006-12-22 2008-07-03 The Institute Of Biological Resources 抗腫瘍剤及びこれを含有する食品
US8486465B1 (en) * 2007-07-09 2013-07-16 Douglas CRAWFORD Therapeutic nerium oleander extract compositions and methods of using
CN101613414B (zh) * 2008-06-26 2011-09-07 中国科学院上海药物研究所 两种夹竹桃寡糖及其制备方法和用途
EP2346518B1 (de) 2008-10-14 2020-09-02 Nerium Biotechnology, Inc. Verfahren zur extraktion von herzglycosiden aus nerium oleader und zusammensetzungen
CN101416988B (zh) * 2008-12-07 2011-12-21 中国热带农业科学院热带生物技术研究所 采食长春花叶的夹竹桃天蛾幼虫粪便提取物在制备抗肿瘤药物中的用途
TR200900312A2 (tr) * 2009-01-15 2010-08-23 Levent Baş Ahmet Nerium oleander'in tip II diyabet, obezite, yüksek kolesterol ve trigliserid düzeyi ile seyreden hastalıklar ve kardiovasküler hastalıklarda kullanımı@
CN110269940A (zh) 2011-10-20 2019-09-24 奈瑞姆生物技术公司 用于治疗癌症的治疗组合
WO2018053123A1 (en) 2016-09-14 2018-03-22 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
US10702567B2 (en) 2016-09-14 2020-07-07 Phoenix Biotechnology, Inc. Method and compositions for treating viral infection
US10596186B2 (en) 2016-09-14 2020-03-24 Phoenix Biotechnology, Inc. Method and compositions for treating viral infections
US10729735B1 (en) 2016-09-14 2020-08-04 Phoenix Biotechnology, Inc. Method and compostitions for treating coronavirus infection
KR102295179B1 (ko) 2017-09-14 2021-08-30 피닉스 바이오테크놀러지 인코포레이티드. 바이러스 감염 치료를 위한 방법 및 조성물
AU2020220204B1 (en) * 2020-03-31 2021-03-25 Phoenix Biotechnology, Inc. Method and compositions for treating Coronavirus infection
MX2020009095A (es) 2020-03-31 2022-07-28 Phoenix Biotechnology Inc Metodo y composiciones para el tratamiento de infeccion por coronavirus.
US11806359B2 (en) 2020-03-31 2023-11-07 Phoenix Biotechnology, Inc. Method and compositions for treating Coronavirus infection
EP4009981B1 (de) 2020-03-31 2023-08-16 Phoenix Biotechnology, Inc. Verfahren und zusammensetzungen zur behandlung von coronavirusinfektionen
CN112689510B (zh) * 2020-03-31 2022-02-01 菲尼克斯生物技术公司 用于治疗冠状病毒感染的方法和组合物
US12097234B2 (en) 2020-05-24 2024-09-24 Phoenix Biotechnology, Inc. Extract containing oleandrin and method of production thereof

Also Published As

Publication number Publication date
CN87104312A (zh) 1988-01-13
NO871978D0 (no) 1987-05-13
PT84857A (en) 1987-06-01
US5135745A (en) 1992-08-04
FI872106A0 (fi) 1987-05-12
JPH0529332B2 (de) 1993-04-30
NO871978L (no) 1987-11-16
AU626516B2 (en) 1992-08-06
AU7278587A (en) 1987-11-19
KR880013565A (ko) 1988-12-21
CA1299100C (en) 1992-04-21
PT84857B (pt) 1990-02-08
NZ220295A (en) 1990-04-26
IL82516A0 (en) 1987-11-30
JPS6322025A (ja) 1988-01-29
FI872106A (fi) 1987-11-14
DK239687D0 (da) 1987-05-12
DK239687A (da) 1987-11-14
MC1811A1 (fr) 1988-03-18

Similar Documents

Publication Publication Date Title
IN168894B (de)
IN169331B (de)
IN165073B (de)
IN168318B (de)
IN170276B (de)
IN170094B (de)
IN169147B (de)
IN172197B (de)
IN167981B (de)
IN168763B (de)
AU5257190A (de)
AU6019186A (de)
AU5597686A (de)
AU4910985A (de)
AU5724586A (de)
AU4946385A (de)
AU5857886A (de)
AU5878886A (de)
AU5130285A (de)
AU5940986A (de)
AU5130385A (de)
AU5173485A (de)
AU5982886A (de)
AU5227086A (de)
AU5684886A (de)